Status: Recruiting
A Study to Investigate Canvuparatide Compared With Placebo in Adult Patients With Hypoparathyroidism
The purpose of this study is to investigate the efficacy and safety of canvuparatide administered as a once-weekly (QW) treatment to adult study participants with hypoparathyroidism (HypoPT).
Participants needed: 160
Trial details
Phase: Phase 3Age: 18+Biological sex: AllType: InterventionalSponsor: MBX BiosciencesUpdated: Jul 13, 2026Locations: 2
Eligibility criteria
Is an adult ≥18 years of age. [+4]
Has a known history of pseudohypoparathyroidism [+4]